DMD research

New Duchenne UK funding call for research into transformative treatments for DMD

Duchenne UK has launched a funding call for research proposals that seek to develop transformative therapies for Duchenne muscular dystrophy (DMD).

We will fund up to £500,000 for projects that are undertaking research into new, safer, and more effective treatments that have the potential to reach the clinic as soon as possible or within up to three years from us funding the programme.

Scope of grant call

We are seeking to fund ambitious, translational projects driving the next generation of transformative DMD therapies, which have the potential to disrupt the current therapeutic landscape leading to marked improvements in the safety, efficacy, including cardiac outcomes, and delivery profile, over current Standards of Care therapies and therapies in the clinical development pipeline.

Examples of therapeutic approaches that we would like to support are:

You can find out more about the eligibility, submission and review process, here.

Published on 24 June 2024

Share this article